Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Image of the MS-UK Helpline button graphic containing a link to the Helpline page

Image of the New Pathways magazine button graphic containing a link to the New Pathways magazine page


In a large nationwide study in Finland, researchers found evidence supporting the link between vitamin D deficiency and an increased risk for multiple sclerosis in women.

The results were...

Preliminary results of a study in Danish patients with multiple sclerosis suggest that inverse comorbidity may exist in the MS population, lowering patients’ risk for other types of diseases. The...

There might be years-long lags in response to disease-modifying drugs in patients with progressive forms of multiple sclerosis, according to a study that analysed data from two large clinical...

Patients with relapsing-remitting multiple sclerosis (RRMS) might benefit from cholecalciferol (vitamin D3) oil as an add-on therapy in the early phases of the disease.

This finding was...

Long-term observations together with mathematical modelling present a way of predicting the likely disability trajectory of multiple sclerosis patients.

The approach was outlined in a...

A pilot study exploring the antioxidant lipoic acid in patients with secondary progressive multiple sclerosis (SPMS) has found that treatment for two years reduced the speed of brain tissue loss...

Children with multiple sclerosis in North America identified a number of challenges in adhering to disease-modifying therapies — a potential first step to devising therapeutic approaches that...

Multiple sclerosis patients in progressive stages of the disease appear to gain some benefit if they take a regimen that includes the antidepressant fluoxetine, researchers suggested at a session...

A blood test that checks for markers of damaging brain activity may give doctors a way to diagnose how well drugs are working in patients with multiple sclerosis (MS), researchers said at the...

The drug has already shown positive Phase II trial results for people with relapsing-remitting MS (RRMS), and now researchers have presented results of their evaluation of a Phase III trial for...

Pages

Live Chat Software by Click4Assistance UK